Human Germline Manipuation and Cloning as Women's Issues
By Marcy Darnovsky,
GeneWatch
| 06. 30. 2001
While the prospect of genetically "redesigned" people challenges humanity as a whole, it particularly threatens groups that historically have been disempowered. And because human germline engineering and cloning are so closely tied to reproduction, they are of special concern to women.
The New Eugenics and the Commercialization of Reproduction
Already, prenatal screening and preimplantation diagnosis make it possible to eliminate fetuses and embryos with a number of identifiable genetic conditions. As disability rights activists point out, these developments put women in the position of "eugenic gatekeepers." Inheritable genetic modification, to whatever extent it turns out to be technically possible, would amplify the powers of eugenic selection many times over.
If a new "free-market eugenics" were to take hold, who would actually exercise "consumer preference" for genetic "enhancements?" Who would decide what was on offer?
Human cloning and germline engineering would move decisions about reproduction further away from women, not only toward doctors and technicians but also toward marketers proffering the "enhancements" developed by biotech companies. Women could find themselves simultaneously losing ever more control of their own childbearing experiences, and...
Related Articles
By Fyodor D. Urnov and Sadik H. Kassim, Nature | 04.21.2026
In February, the US Food and Drug Administration (FDA) proposed a radical rethink of how scientists, physicians and manufacturers develop personalized genetic therapies. The regulator’s suggested introduction of a ‘plausible mechanism pathway’ should increase incentives for drug companies to develop...
By Miguel Muñoz, Cadena SER | 08.04.2026
"Para ellos, una familia numerosa no solo es una preferencia personal, sino que es una obligación. Creen que tener tantos hijos como sea posible es necesario para evitar un futuro apocalíptico", aseguraba Xavier Orri, periodista y cofundador de Página Internacional...
By Ryan Knutson and Jessica Mendoza, The Journal. | 03.27.2026
Genetically engineered babies are banned in the U.S. But that isn’t stopping Silicon Valley tech titans from trying to make one. In this final installment from The Journal’s investigation into the fringes of the fertility industry, WSJ’s Emily Glazer reports...
By Antonio Regalado, MIT Technology Review | 03.30.2026
After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing.
In...